Paraneoplastic necrotizing myelopathy in a patient with advanced esophageal cancer: An autopsied case report.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 19272613)

Published in J Neurol Sci on March 09, 2009

Authors

Yoshiteru Urai1, Kouichi Matsumoto, Mieko Shimamura, Kazuyo Ikeda, Masago Tsukaguchi, Kazushi Deguchi, Tetsuo Touge, Masaki Ueno, Haruhiko Sakamoto, Shigeki Kuriyama, Fumihiko Kinekawa, Kazutaka Kurokohchi, Naohito Uchida, Tsutomu Masaki

Author Affiliations

1: Department of Gastroenterology and Neurology, School of Medicine, Kagawa University, Japan. yurai@med.kagawa-u.ac.jp

Articles by these authors

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet (2012) 4.84

Expression of Epstein-Barr virus in Langerhans' cell histiocytosis. Hum Pathol (2004) 2.35

Bloc biopsy by using submucosal endoscopy with a mucosal flap method for gastric subepithelial tumor tissue sampling (with video). Gastrointest Endosc (2012) 2.15

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology (2002) 2.06

The rare sugar D-allose has a reducing effect against ischemia-reperfusion injury on the rat abdominal skin island flap model. J Surg Res (2013) 1.97

Colon interposition after esophagectomy with extended lymphadenectomy for esophageal cancer. Ann Thorac Surg (2009) 1.81

Efficacy and safety of over-the-scope clip: including complications after endoscopic submucosal dissection. World J Gastroenterol (2013) 1.80

Defective brain development in mice lacking the Hif-1alpha gene in neural cells. Mol Cell Biol (2003) 1.75

Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. Hepatology (2004) 1.73

Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer. J Clin Oncol (2005) 1.67

Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. Clin Immunol (2012) 1.67

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo. Mol Cancer Ther (2012) 1.57

Steroid permeation into the artificial ulcer by combined steroid gel application and balloon dilatation: prevention of esophageal stricture. J Gastroenterol Hepatol (2013) 1.55

Cytomegalovirus-associated acute gastric mucosal lesion in an immunocompetent host. Intern Med (2009) 1.54

Indication and procedure for treatment of hepatolithiasis. Arch Surg (2002) 1.53

Pre-cutting using a noseless papillotome with independent lumens for contrast material and guidewire. J Gastroenterol Hepatol (2005) 1.53

Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system. Hypertens Res (2009) 1.51

Reduced expression of cell cycle regulator p18(INK4C) in human hepatocellular carcinoma. Hepatology (2004) 1.48

Esophageal function worsens with long duration of diabetes. J Gastroenterol (2008) 1.42

Bone marrow-engrafted cells after mice umbilical cord blood transplantation differentiate into osteoblastic cells in response to fracture and placement of titanium screws. Exp Anim (2012) 1.41

Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma. Int J Oncol (2008) 1.33

EUS-guided fine-needle tissue acquisition by using a 19-gauge needle in a selected patient population: a prospective study. Gastrointest Endosc (2011) 1.33

Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis. Hepatology (2003) 1.31

Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts. Arthritis Rheum (2007) 1.28

Reducing residual and recurrent stones by hepatectomy for hepatolithiasis. J Gastrointest Surg (2007) 1.21

Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol (2005) 1.20

A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood (2003) 1.18

Overexpression of matrix metalloproteinase-7 (MMP-7) correlates with tumor proliferation, and a poor prognosis in non-small cell lung cancer. Lung Cancer (2007) 1.18

Wnt1 overexpression promotes tumour progression in non-small cell lung cancer. Eur J Cancer (2008) 1.18

E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clin Cancer Res (2007) 1.17

Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat. Int J Oncol (2002) 1.17

A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2012) 1.16

Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion (2002) 1.16

Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma. Hepatology (2002) 1.14

The importance of grouping of lymph node stations and rationale of three-field lymphoadenectomy for thoracic esophageal cancer. J Surg Oncol (2012) 1.13

Engulfment of axon debris by microglia requires p38 MAPK activity. J Biol Chem (2009) 1.13

Involvement of the Olig2 transcription factor in cholinergic neuron development of the basal forebrain. Dev Biol (2006) 1.10

Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats. Am J Physiol Gastrointest Liver Physiol (2004) 1.09

The evaluation of duct-to-mucosal pancreaticojejunostomy in pancreaticoduodenectomy. World J Surg (2005) 1.09

Blockade of renin-angiotensin system in antifibrotic therapy. J Gastroenterol Hepatol (2007) 1.08

Topographic anatomy and laparoscopic technique for dissection of no. 6 infrapyloric lymph nodes in gastric cancer surgery. Gastric Cancer (2013) 1.08

Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. Int J Oncol (2005) 1.08

The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer (2008) 1.08

Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats. J Hepatol (2002) 1.08

Genetic deletion of paired immunoglobulin-like receptor B does not promote axonal plasticity or functional recovery after traumatic brain injury. J Neurosci (2010) 1.07

Long-term prognosis after treatment of patients with choledocholithiasis. Ann Surg (2003) 1.05

MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene (2004) 1.05

Rectal perforations and fistulae secondary to a glycerin enema: closure by over-the-scope-clip. World J Gastroenterol (2012) 1.05

Wnt1 overexpression associated with tumor proliferation and a poor prognosis in non-small cell lung cancer patients. Oncol Rep (2008) 1.04

Mediastinal pancreatic pseudocyst caused by obstruction of the pancreatic duct was eliminated by bromhexine hydrochloride. Intern Med (2004) 1.03

Angiotensin-I-converting enzyme inhibitors may be an alternative anti-angiogenic strategy in the treatment of liver fibrosis and hepatocellular carcinoma. Possible role of vascular endothelial growth factor. Tumour Biol (2003) 1.03

Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury. J Biol Chem (2010) 1.02

Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Int J Oncol (2005) 1.02

Tissue inhibitor of metalloproteinases-1 (TIMP-1) inhibits tumor growth and angiogenesis in the TIMP-1 transgenic mouse model. Int J Cancer (2003) 1.02

Regional- and temporal-dependent changes in the differentiation of Olig2 progenitors in the forebrain, and the impact on astrocyte development in the dorsal pallium. Dev Biol (2008) 1.01

Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion. PLoS One (2012) 1.01

Successful closing of duodenal ulcer after endoscopic submucosal dissection with over-the-scope clip to prevent delayed perforation. Dig Endosc (2012) 1.01

Xanthogranulomatous cholecystitis: the use of preoperative CT findings to differentiate it from gallbladder carcinoma. J Hepatobiliary Pancreat Surg (2009) 1.01

Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages. Clin Immunol (2009) 1.00

Galectin-9 expression links to malignant potential of cervical squamous cell carcinoma. J Cancer Res Clin Oncol (2008) 1.00

Gene therapy for human colorectal carcinoma using human CEA promoter contro led bacterial ADP-ribosylating toxin genes human CEA: PEA & DTA gene transfer. World J Gastroenterol (1998) 1.00

Activated microglia inhibit axonal growth through RGMa. PLoS One (2011) 1.00

Galectin-9 expands immunosuppressive macrophages to ameliorate T-cell-mediated lung inflammation. Eur J Immunol (2010) 1.00

Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors. Int J Oncol (2004) 0.99

Antitumor effect of metformin in esophageal cancer: in vitro study. Int J Oncol (2012) 0.99

Human microRNAs originated from two periods at accelerated rates in mammalian evolution. Mol Biol Evol (2012) 0.98

Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol (2004) 0.98

Rapid onset of glycogen storage hepatomegaly in a type-2 diabetic patient after a massive dose of long-acting insulin and large doses of glucose. Intern Med (2006) 0.98

Development of hepatocytes from ES cells after transfection with the HNF-3beta gene. FASEB J (2002) 0.98

Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma. Int J Oncol (2004) 0.98

Analysis of the beta-catenin/T cell factor signaling pathway in 36 gastrointestinal and liver cancer cells. Jpn J Cancer Res (2002) 0.98

Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2011) 0.98

Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab (2002) 0.97

Blood-brain barrier is impaired in the hippocampus of young adult spontaneously hypertensive rats. Acta Neuropathol (2004) 0.97

Adenocarcinoma arising from aberrant pancreas in the stomach. J Gastroenterol (2005) 0.97

Thoracoscopic ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma located immediately under the diaphragm. Int J Oncol (2006) 0.97